Recombinant Proteins Market: Is 2026 the Year AI-Driven De Novo...

Ajouter une nouvelle offre d'emploi Health

2026-03-05 11:13:07 -

Recombinant Proteins Market: Is 2026 the Year AI-Driven De Novo Design Replaces Trial-and-Error Discovery

The architectural foundation of modern biotechnology is undergoing a radical shift in 2026, with the Recombinant Proteins Market projected to reach a valuation of $3.7 billion this year. The 2026 landscape is defined by the integration of "Generative AI" and "De Novo Protein Design," where researchers are no longer limited to proteins found in nature. In 2026, AI models are being used to...

0 Commentaires 0 Parts 49 Vue 0 Aperçu